BioMarin Pharmaceutical, Inc. (BMRN)
58.51
-0.56
(-0.95%)
USD |
NASDAQ |
Mar 13, 16:00
59.21
+0.70
(+1.20%)
Pre-Market: 08:00
BioMarin Pharmaceutical EPS Diluted (Quarterly) : -0.2423 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| Gilead Sciences, Inc. | 1.742 |
| Merck & Co., Inc. | 1.191 |
| MannKind Corp. | -0.0519 |
| AbbVie, Inc. | 1.018 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.57M |
| Revenue (Quarterly) | 895.02M |
| Total Expenses (Quarterly) | 941.59M |
| Enterprise Value | 10.34B |
| Gross Profit Margin (Quarterly) | 68.65% |
| Profit Margin (Quarterly) | -5.20% |
| Earnings Yield | 3.05% |
| Operating Earnings Yield | 7.18% |
| Normalized Earnings Yield | 5.443 |